News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Innovator Hospitals Bring ICUs into the Info Age, Using New Design Approaches that involve Medical Laboratory Tests

By consolidating information, automating data collection, and harnessing new cloud computing technologies, doctors hope to silence the endless array of alarms and inject efficiency and personalization into the critical care experience

Some healthcare experts believe it is time that intensive care units undergo a workflow redesign to improve the quality of care they deliver, while reducing or eliminating design elements that contribute to errors. Clinical laboratories have a stake in this redesign effort, as they provide medical laboratory tests for patients in ICUs.

“What I want to do for the ICU is what Steve Jobs did for the iPhone,” said Peter Pronovost, PhD, MD, in an article published in STAT. Pronovost is working to improve both the flow of information and delivery of care in the ICU of Johns Hopkins Hospital in Baltimore, Maryland. (more…)

ONC Releases Final Rule for Stage 3 Meaningful Use: What Most Affects Clinical Laboratories and Anatomic Pathology Groups

Meaningful Use Stage 3 focuses on interoperability, which is good news for medical laboratories that must spend time and money to develop effective LIS-EHR interfaces

On December 15, 2015, the final rule for Stage 3 meaningful use (MU) went into effect. By now, pathologists and clinical laboratory managers and personnel are well-acquainted with the MU incentive program and the myriad of challenges it presents for almost everyone working in the healthcare sector.

Although the implementation of electronic health records (EHRs) has caused labs some headaches, the Stage 3 MU requirements could reduce some of that pressure. One of the biggest changes in Stage 3, according to the Office of the Federal Register (OFR), is that the ONC is “finalizing changes to remove the menu and core structure of Stage 1 and Stage 2 and reduce the number of objectives to which a provider must attest.” There will be fewer objectives to prove an EHR system is being used in a meaningful way.

That’s good news for providers struggling with EHR attestation. However, the struggle for clinical laboratories isn’t with attestation per se, it’s with interoperability between lab information systems (LIS) and physicians’ EHRs. (more…)

Physicians Embrace mHealth Technology, Creating New Opportunities for Clinical Laboratories to Add Value

Mobile health devices can allow physicians to consult with pathologists in real time

Mobile-health technology (mHealth) is the hot ticket with physicians. The advent of mobile computing, smartphones, and iPad-types of devices are fueling a strong demand by physicians for mobile apps that can help them receive alerts, stay informed of patient progress, access lab test results, and contact patients.

This is a swift-moving trend and clinical laboratory managers will want to develop information technology (IT) strategies to serve this keen interest by physicians to use their mobile-health devices to order medical laboratory tests and receive laboratory test results.

(more…)

Cyber-Attacks against Internet-Enabled Medical Devices are New Threat to Clinical Pathology Laboratories

Veterans Administration and Hospitals Taking Steps to Prevent Hacking of Medical Devices and Wireless Systems

Clinical laboratories and anatomic pathology groups face a growing security threat to the integrity of their analyzers, laboratory information systems (LIS), and other devices used daily by their employees.

This rapidly-developing threat comes from outside hackers who are launching cyber-attacks aimed at the various medical devices and wireless systems that are directly connected to the Internet and are used by hospitals, physicians, and other healthcare providers. These cyber-attacks demonstrate a new vulnerability that clinical laboratories and pathology groups should recognize.

(more…)

;